Inventor
Cynthia L. Palmer
Inventor
La Mesa, CA, US
Overview
Patents· 36 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds49%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%
A61KPreparations for medical, dental or toiletry purposes7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
C10MLubricating compositions1%
C10NIndexing scheme associated with subclass c10m relating to lubricating compositions1%
C11DDetergent compositions1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
10,800,783CDK2/4/6 inhibitors202010,766,884Cyclin dependent kinase inhibitors202010,662,204Substituted quinazoline and pyridopyrimidine derivatives useful as anticancer agents202010,590,115Tetrahydroquinazoline derivatives useful as anticancer agents20209,133,215'Macrocyclic derivatives for the treatment of diseases'20158,916,593'Alkoxy-substituted 2-aminopyridines as ALK inhibitors'20148,680,111'Macrocyclic derivatives for the treatment of diseases'20147,772,246'Pyrazole compounds as RAF inhibitors'20107,141,587'Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use'20067,053,107'Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use'20067,045,528'Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use'20066,891,044'Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their use'20056,884,890'Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use'20056,869,962'Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use'20056,635,641'Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use'20036,534,524'Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use'20036,531,491'Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use'20036,525,050'(4-oxo-2-pyrimidinyl)thioalkyl compounds useful as AICARFT inhibitors'20036,323,210'Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds'20016,207,670'Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds'20015,981,748'Synthesis of optically pure compounds useful as GARFT inhibitors and their intermediates'19995,945,427'Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds'19995,831,100'Syntheses of optically pure compounds useful as GARFT inhibitors and their intermediates'19985,804,545'Stable alkaline chlorine compositions'19985,739,141'Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds'19985,726,312'Methods for preparing antiproliferative 5-substituted pyrimidone compounds'19985,723,607'Compounds useful as antiproliferative agents and GARFT inhibitors'19985,663,131'Conveyor lubricants which are compatible with pet containers'19975,641,771'Compounds useful as antiproliferative agents and garft inhibitors'19975,641,774'Compounds useful as antiproliferative agents and garft inhibitors'19975,639,747'Compounds useful as antiproliferative agents and garft inhibitors'19975,639,749'Compounds useful as antiproliferative agents and garft inhibitors'19975,625,061'Compounds useful in preparing antiproliferative agents and garft inhibitors'19975,610,319'Compound useful as antiproliferative agents and GARFT inhibitors'19975,594,139'Processes for preparing antiproliferative garft-inhibiting compounds'19975,574,039'Antiproliferative compounds having nitrogen-containing tricyclic ring systems and phenyl substituents'1996Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1996–2006Patents assigned to AGOURON PHARMA (24)· patent assignee history
1996–2020Based in La Mesa, CA, US· patent location history
1997–1998Based in Kansas City, MO, US· patent location history
1998Patents assigned to AGOURON PHARMACETICALS INC (1)· patent assignee history
2003Patents assigned to AGOURON PHARAMACEUTICALS INC (1)· patent assignee history
2003–2020Based in San Diego, CA, US· patent location history
2010–2020Patents assigned to PFIZER (8)· patent assignee history
2014Patents assigned to BUNNAGE MARK EDWARD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AGOURON PHARMA | 24 | 1996–2006 |
| PFIZER | 8 | 2010–2020 |
| AGOURON PHARAMACEUTICALS INC | 1 | 2003 |
| AGOURON PHARMACETICALS INC | 1 | 1998 |
| BUNNAGE MARK EDWARD | 1 | 2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| La Mesa, California, US | 29 | 1996–2020 |
| San Diego, California, US | 5 | 2003–2020 |
| Kansas City, MO, US | 2 | 1997–1998 |